Regulation of nuclear factor-κB in intestinal epithelial cells in a cell model of inflammation

Mediators of Inflammation

Volumn 12, Issue 5, 2003, Pages 277-283

  Homaidan, Fadia R ^a   Chakroun, Iman ^a   El Sabban, Marwan E ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

Inflammation; Inflammatory bowel disease; Interleukin 1; Intestinal epithelial cells; Nuclear factor B

Indexed keywords

APOPTOSIS INDUCING FACTOR; CERAMIDE; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; MESSENGER RNA; TRANSCRIPTION FACTOR;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL PROTECTION; CONTROLLED STUDY; ELECTROPHORETIC MOBILITY; ENTERITIS; EPITHELIUM CELL; GENE EXPRESSION REGULATION; INFLAMMATION; INFLAMMATORY CELL; INTESTINE EPITHELIUM; INTESTINE MUCOSA; MEDIATOR RELEASE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FAMILY; PROTEIN PHOSPHORYLATION; TARGET CELL;

ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BCL-X PROTEIN; CELL LINE; CERAMIDES; CYSTEINE PROTEINASE INHIBITORS; ENTERITIS; EPITHELIAL CELLS; I-KAPPA B PROTEINS; INTERLEUKIN-1; INTESTINAL MUCOSA; LEUPEPTINS; NF-KAPPA B; PROTEINS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; RNA, MESSENGER;

ANIMALIA;

EID: 0242524675     PISSN: 09629351     EISSN: None     Source Type: Journal    
DOI: 10.1080/09629350310001619681     Document Type: Article

References (34)

1. Baldwin AS. The NF-κB and IκB proteins: new discoveries and insights. Annu Rev Immunol 1996; 14: 649-683.
2. Barnes PJ, Karin M. Nuclear factor-κB - a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 1997; 336: 1066-1071.
3. Baeuerle PA, Henkel T. Function and activation of NF-κB in the immune system. Annu Rev Immunol 1994; 12: 141-179.
4. Thonas D, Maniatis T. Identification of the rel family members required for virus induction of the human beta interferon gene. Mol Cell Biol 1995; 15: 152-164.
5. Thonas D, Maniatis T. NF kappa B: a lesson in family values. Cell 1995; 80: 529-532.
6. Finco TS, Baldwin AS. Mechanistic aspects of NF kappa B regulation: the emerging role of phosphorylation and proteolysis. Immunity 1995; 3: 263-272.
7. Gilmore TD, Morin PJ. The I-κB proteins: members of a multifunctional family. Trends Genet 1993; 9: 427-433.
8. Brown K, Gerstberger S, Carlson L, Franzoso G, Siebenlist U. Control of IκB-α proteolysis by site-specific, signal-induced phosphorylation. Science 1995; 267: 1485-1488.
9. Traenckner EBM, Pahl HL, Henkel T, Schmidt KN, Wilk S, Baeuerle PA. Phosphorylation of human IκB-α on serines 32 and 36 controls IκB-α proteolysis and NF-κB activation in response to diverse stimuli. EMBO J 1995; 14: 2876-2883.
10. Homaidan FR, Chakroun I, Dbaibo GS, El-Assaad W, El-Sabban ME. IL-1 activates two phospholipid signaling pathways in intestinal epithelial cells. Inflamm Res 2001; 50: 375-381.
11. Homaidan FR, Chakroun I, EJ-Sibai M, Dbaibo GS, El-Sabban ME. IL-1 stimulates ceramide levels without inducing apoptosis in intestinal epithelial cells. Mediat Inflamm 2002; 11: 39-45.
12. Yamamato K, Arakawa T, Ueda N, Yamamato S. Transcriptional role of nuclear factor κβ and nuclear factor interleukin-6 in the tumor necrosis factor α-dependent induction of cyctoxygenase-2 in MC 3T3-E1 cells. J Biol Chem 1995; 270: 31315-31320.
13. Beg AA, Sha WC, Bronson RT, Baltimore D. Embryonic lethality and liver degeneration in mice lacking the Rel-A component of NF-kappa B. Nature 1995; 376: 167-170.
14. Bauerle PA, Baltimore D. NF-kappa B: ten years after. Cell 1996; 87: 13-20.
15. Abbadie C, Kaburn N, Boudi F, Smardova J, Stehelin D, Vandenbunder B, Enrietto PJ. High levels of c-re1 expression are associated with programmed cell death in the developing avian embryo and in bone marrow cells in vitro. Cell 1993; 75: 899-918.
16. Vidal K, Grosjean I, Revillard JP, Gespach C, Kaiserlian D. Immortalization of mouse intestinal epithelial cells by SV40-large T gene. Phenotypic and immune characterization of the Mode-K cell line. J Immunol Methods 1993; 166: 63-73.
17. Reed JC. Bcl-2 family proteins: regulators of apoptosis and chemoresistance in hematologic malignancies. Semin Hematol 1997; 34: 9-19.
18. Mustapha S, Kirshner A, De Moissac D, Kirshenbaum LA. A direct requirement of nuclear factor-κB for suppression of apoptosis in ventricular myocytes. Am J Physiol 2000; 279: H939-H945.
19. Van Atwerp DJ, Martin SJ, Kafri T, Green DR, Verma IM. Suppression of TNF-κ-induced apoptosis by NF-κB. Science 1996; 274: 787-789.
20. Wang CY, Mayo MW, Baldwin AS Jr. TNF-and cancer therapy-induced apoptosis: potentiation by inhibition of NF-κB. Science 1996; 274: 784-787.
21. Jobin C, Sartor BR. The IkB/NF-kB system: a key determinant of mucosal inflammation and protection. Am J Physiol 2000; 278: C451-C462.
22. Hideshima T, Mitsiades C, Akiyama, et al. Molecular mechanisms mediating antimycloma activity of proteasome inhibitor PS-341. Blood 2003; 101: 1530-1534.
23. Aghajanian C, Soignet S, Dizon DS, et al. A phase I trial of the novel proteasome inhibitor PS341 in advanced solid tumor malignancies. Clin Cancer Res 2002; 8: 2505-2511.
24. Orlowski RZ, Stinchcombe TE, Mitchell BS, et al. Phase I trial of the proteasome inhibitor PS-341 in patients with refractory hematologic malignancies. J Clin Oncol 2002; 20: 4420-4427.
25. Keates S, Hitti Y, Upton M, Kelly C. Helicobacter pylori infection activates NF-κB in gastric epithelial cells. Gastroenterology 1997; 113: 1099-1109.
26. Wahl C, Liptay S, Adler G, Schmid R. Sulfasalazine: a potent and specific inhibitor of nuclear factor kappa B. J Clin Invest 1998; 101: 1163-1174.
27. Guvosky I, Guvoskaya A, Blinman T, Zaninovic V, Pandol S. Early NF-κB activation is associated with hormone-induced pancreatitis. Am J Physiol 1998; 275: G1402-G1414.
28. Pausawasdi N, Ramamoorthy S, Crofford LJ, Askari FK, Todisco A. Regulation and function of COX-2 gene expression in isolated gastric parietal cells. Am J Physiol 2002; 282: G1069-G1078.
29. Schutze S, Potthoff K, Machleidt T, Berkovic D, Wiegman K, Kronke M. TNF activates NF-kB by phosphatidylcholine specific phospholipase C-induced 'acidic' sphingomyelin breakdown. Cell 1992; 71: 765-776.
30. Reddy SAG, Chaturvedi M, Darnay BG, Chan H, Higuchi M, Aggarwal BB. Reconstitution of nuclear factor KB activation induced by tumor necrosis factor requires membrane-associated components. J Biol Chem 1994; 269: 25369-25372.
31. Zumbansen M, Stoffel W. Tumor necrosis factor a activates NFκB in acid sphingomyelinase-deficient mouse embryonic fibroblasts. J Biol Chem 1997; 272: 10904-10909.
32. Chen CC, Sun YT, Chen JJ, Chang YJ. Tumor necrosis factor-α- induced cyclooxygenase-2 expression via sequential activation of ceramide-dependent mitogen-activated protein kinases, and IκB kinase 1/2 in human alveolar epithelial cells. Mol Pharmacol 2001; 59: 493-500.
33. Di Donato JA, Hayakawa M, Rothwarf DM, Zandi E, Karin M. A cytokine-responsive IκB kinase that activates the transcription factor NF-κB. Nature 1997; 388: 548-554.
34. Zandi E, Chen Y, Karin M. Direct phosphorylation of IκB by IKKα and IKKβ: discrimination between free and NF-κB-bound substrate. Science 1998; 281: 1360-1363.